<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37027074</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-6830</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cellular and molecular neurobiology</Title><ISOAbbreviation>Cell Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review.</ArticleTitle><Pagination><StartPage>2643</StartPage><EndPage>2673</EndPage><MedlinePgn>2643-2673</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10571-023-01344-6</ELocationID><Abstract><AbstractText>Stem cells have been the subject of research for years due to their enormous therapeutic potential. Most neurological diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD) are incurable or very difficult to treat. Therefore new therapies are sought in which autologous stem cells are used. They are often the patient's only hope for recovery or slowing down the progress of the disease symptoms. The most important conclusions arise after analyzing the literature on the use of stem cells in neurodegenerative diseases. The effectiveness of MSC cell therapy has been confirmed in ALS and HD therapy. MSC cells slow down ALS progression and show early promising signs of efficacy. In HD, they reduced huntingtin (Htt) aggregation and stimulation of endogenous neurogenesis. MS therapy with hematopoietic stem cells (HSCs) inducted significant recalibration of pro-inflammatory and immunoregulatory components of the immune system. iPSC cells allow for accurate PD modeling. They are patient-specific and therefore minimize the risk of immune rejection and, in long-term observation, did not form any tumors in the brain. Extracellular vesicles derived from bone marrow mesenchymal stromal cells (BM-MSC-EVs) and Human adipose-derived stromal/stem cells (hASCs) cells are widely used to treat AD. Due to the reduction of A&#x3b2;42 deposits and increasing the survival of neurons, they improve memory and learning abilities. Despite many animal models and clinical trial studies, cell therapy still needs to be refined to increase its effectiveness in the human body.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cecerska-Hery&#x107;</LastName><ForeName>El&#x17c;bieta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, PowstancowWielkopolskich 72, 70-111, Szczecin, Poland. elzbieta.cecerska.heryc@pum.edu.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#x119;ka&#x142;a</LastName><ForeName>Maja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, PowstancowWielkopolskich 72, 70-111, Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serwin</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, PowstancowWielkopolskich 72, 70-111, Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gli&#x17a;niewicz</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, PowstancowWielkopolskich 72, 70-111, Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grygorcewicz</LastName><ForeName>Bart&#x142;omiej</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, PowstancowWielkopolskich 72, 70-111, Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michalczyk</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Pomeranian Medical University of Szczecin, Broniewskiego 26, 71-460, Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hery&#x107;</LastName><ForeName>Rafa&#x142;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University of Szczecin, PowstancowWielkopolskich 72, 70-111, Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budkowska</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Analytics, Pomeranian Medical University of Szczecin, PowstancowWielkopolskich 72, 70-111, Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Do&#x142;&#x119;gowska</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, PowstancowWielkopolskich 72, 70-111, Szczecin, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Mol Neurobiol</MedlineTA><NlmUniqueID>8200709</NlmUniqueID><ISSNLinking>0272-4340</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="Y">Huntington Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">Amyotropic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Huntington's disease</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword><Keyword MajorTopicYN="N">Parkinson's disease</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37027074</ArticleId><ArticleId IdType="pmc">PMC10333383</ArticleId><ArticleId IdType="doi">10.1007/s10571-023-01344-6</ArticleId><ArticleId IdType="pii">10.1007/s10571-023-01344-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ager RR, et al. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of alzheimer's disease and neuronal loss. Hippocampus. 2015;25(7):813&#x2013;826. doi: 10.1002/hipo.22405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.22405</ArticleId><ArticleId IdType="pmc">PMC4722865</ArticleId><ArticleId IdType="pubmed">25530343</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O, Kiernan MC, Chi&#xf2; A, Rix-Brooks B, van den Berg LH. Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol. 2016;15(11):1182&#x2013;1194. doi: 10.1016/S1474-4422(16)30199-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30199-5</ArticleId><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Gharaibeh A, Culver R, Stewart AN, et al. Induced pluripotent stem cell-derived neural stem cell transplantations reduced behavioral deficits and ameliorated neuropathological changes in YAC128 mouse model of Huntington's disease. Front Neurosci. 2017;10(11):628. doi: 10.3389/fnins.2017.00628.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00628</ArticleId><ArticleId IdType="pmc">PMC5701605</ArticleId><ArticleId IdType="pubmed">29209158</ArticleId></ArticleIdList></Reference><Reference><Citation>Amyotrophic lateral sclerosis (ALS) fact sheet.National Institute of Neurological Disorders and Stroke website. ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Amyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet. Updated 30.01, 2023</Citation></Reference><Reference><Citation>Ayala-Cuellar AP, Kang J-H, et al. Roles of mesenchymal stem cells in tissue regeneration and immunomodulation. Biomol Ther (Seoul). 2019;27(1):25&#x2013;33. doi: 10.4062/biomolther.2017.260.</Citation><ArticleIdList><ArticleId IdType="doi">10.4062/biomolther.2017.260</ArticleId><ArticleId IdType="pmc">PMC6319543</ArticleId><ArticleId IdType="pubmed">29902862</ArticleId></ArticleIdList></Reference><Reference><Citation>Barczewska M, Maksymowicz S, Zdoli&#x144;ska-Malinowska I, et al. Umbilical cord mesenchymal stem cells in amyotrophic lateral sclerosis: an original study. Stem Cell Rev Rep. 2020;16(5):922&#x2013;932. doi: 10.1007/s12015-020-10016-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-10016-7</ArticleId><ArticleId IdType="pmc">PMC7456414</ArticleId><ArticleId IdType="pubmed">32725316</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker RA, Mason SL, Harrower TP, et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington&#x2019;s disease. J Neurol Neurosurg Psychiatry. 2013;84(6):657&#x2013;665. doi: 10.1136/jnnp-2012-302441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-302441</ArticleId><ArticleId IdType="pmc">PMC3646287</ArticleId><ArticleId IdType="pubmed">23345280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellingacci L, Mancini A, Gaetani L, Tozzi A, Parnetti L, Di Filippo M. Synaptic dysfunction in multiple sclerosis: a red thread from inflammation to network disconnection. Int J Mol Sci. 2021;22:9753. doi: 10.3390/ijms22189753.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22189753</ArticleId><ArticleId IdType="pmc">PMC8469646</ArticleId><ArticleId IdType="pubmed">34575917</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry JD, Cudkowicz ME, Windebank AJ, Staff NP, et al. NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results. Neurology. 2019;93(24):e2294&#x2013;e2305. doi: 10.1212/WNL.0000000000008620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008620</ArticleId><ArticleId IdType="pmc">PMC6937497</ArticleId><ArticleId IdType="pubmed">31740545</ArticleId></ArticleIdList></Reference><Reference><Citation>Boika A, Aleinikava N, Chyzhyk V, Zafranskaya M, Nizheharodava D, Ponomarev V. Mesenchymal stem cells in Parkinson's disease: Motor and nonmotor symptoms in the early posttransplant period. Surg Neurol Int. 2020;11(11):380. doi: 10.25259/SNI_233_2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.25259/SNI_233_2020</ArticleId><ArticleId IdType="pmc">PMC7771400</ArticleId><ArticleId IdType="pubmed">33408914</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond AM, Berg DA, Lee S, Garcia-Epelboim AS, Adusumilli VS, Ming GL, Song H. Differential timing and coordination of neurogenesis and astrogenesis in developing mouse hippocampal subregions. Brain Sci. 2020;10:909. doi: 10.3390/brainsci10120909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10120909</ArticleId><ArticleId IdType="pmc">PMC7760658</ArticleId><ArticleId IdType="pubmed">33255945</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Alhalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt MF, Martinez FJ, Wright S, et al. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol Cell Neurosci. 2013;56:355&#x2013;364. doi: 10.1016/j.mcn.2013.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2013.07.007</ArticleId><ArticleId IdType="pmc">PMC4772428</ArticleId><ArticleId IdType="pubmed">23891805</ArticleId></ArticleIdList></Reference><Reference><Citation>Burt RK, Balabanov R, Burman J, et al. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. JAMA. 2019;321(2):165&#x2013;174. doi: 10.1001/jama.2018.18743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.18743</ArticleId><ArticleId IdType="pmc">PMC6439765</ArticleId><ArticleId IdType="pubmed">30644983</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne JA. Developing neural stem cell-based treatments for neurodegenerative diseases. Stem Cell Res Ther. 2014;5:72. doi: 10.1186/scrt461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/scrt461</ArticleId><ArticleId IdType="pmc">PMC4076634</ArticleId><ArticleId IdType="pubmed">25157920</ArticleId></ArticleIdList></Reference><Reference><Citation>Cable J, Fuchs E, Weissman I, Jasper H, Glass D, Rando TA, Blau H, Debnath S, Oliva A, Park S, Passegu&#xe9; E, Kim C, Krasnow MA. Adult stem cells and regenerative medicine - a symposium report. Ann N Y Acad Sci. 2020;1462(1):27&#x2013;36. doi: 10.1111/nyas.14243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14243</ArticleId><ArticleId IdType="pmc">PMC7135961</ArticleId><ArticleId IdType="pubmed">31655007</ArticleId></ArticleIdList></Reference><Reference><Citation>Camnasio S, Carri AD, Lombardo A, Grad I, Mariotti C, Castucci A, et al. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington&#x2019;s disease patients demonstrates mutation relate d enhanced lysosomal activity. Neurobiol Dis. 2012;46:41&#x2013;51. doi: 10.1016/j.nbd.2011.12.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.12.042</ArticleId><ArticleId IdType="pubmed">22405424</ArticleId></ArticleIdList></Reference><Reference><Citation>Carstens M, Haq I, Martinez-Cerrato J, et al. Sustained clinical improvement of Parkinson's disease in two patients with facially-transplanted adipose-derived stromal vascular fraction cells. J ClinNeurosci. 2020;81:47&#x2013;51. doi: 10.1016/j.jocn.2020.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.09.001</ArticleId><ArticleId IdType="pubmed">33222965</ArticleId></ArticleIdList></Reference><Reference><Citation>Casarosa S, Bozzi Y, Conti L. Neural stem cells: ready for therapeutic applications? Mol Cell Ther. 2014;2:31. doi: 10.1186/2052-8426-2-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2052-8426-2-31</ArticleId><ArticleId IdType="pmc">PMC4452059</ArticleId><ArticleId IdType="pubmed">26056597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang KA, Kim HJ, Joo Y, et al. The therapeutic effects of human adipose-derived stem cells in alzheimer&#x2019;s disease mouse models. Neurodegener Dis. 2014;13:99&#x2013;102. doi: 10.1159/000355261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000355261</ArticleId><ArticleId IdType="pubmed">24157626</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WW, Blurton-Jones M. Concise review: can stem cells be used to treat or model alzheimer's disease? Stem Cells. 2012;30(12):2612&#x2013;8. doi: 10.1002/stem.1240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1240</ArticleId><ArticleId IdType="pmc">PMC3508338</ArticleId><ArticleId IdType="pubmed">22997040</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WS, Xu PZ, Gottlob K, et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 2001;15:2203&#x2013;2208. doi: 10.1101/gad.913901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.913901</ArticleId><ArticleId IdType="pmc">PMC312770</ArticleId><ArticleId IdType="pubmed">11544177</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiavellini P, Canatelli-Mallat M, Lehmann M, et al. Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders. Neural Regen Res. 2022;17(3):469&#x2013;476. doi: 10.4103/1673-5374.320966.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.320966</ArticleId><ArticleId IdType="pmc">PMC8504380</ArticleId><ArticleId IdType="pubmed">34380873</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi KA, Hong S. Induced neural stem cells as a means of treatment in Huntington's disease. Expert OpinBiol Ther. 2017;17(11):1333&#x2013;1343.</Citation><ArticleIdList><ArticleId IdType="pubmed">28792249</ArticleId></ArticleIdList></Reference><Reference><Citation>Connor B. Concise review: the use of stem cells for understanding and treating huntington&#x2019;s disease. Stem Cells. 2018;36:146&#x2013;160. doi: 10.1002/stem.2747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2747</ArticleId><ArticleId IdType="pubmed">29178352</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D, Genever P. Regulation of mesenchymal stem cell differentiation. Adv Exp Med Biol. 2013;786:213&#x2013;229. doi: 10.1007/978-94-007-6621-1_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-94-007-6621-1_12</ArticleId><ArticleId IdType="pubmed">23696359</ArticleId></ArticleIdList></Reference><Reference><Citation>Correale J, Gait&#xe1;n MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 2017;140(3):527&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">27794524</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyle PK. What can we learn from sex differences in MS? J Pers Med. 2021;11:1006. doi: 10.3390/jpm11101006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11101006</ArticleId><ArticleId IdType="pmc">PMC8537319</ArticleId><ArticleId IdType="pubmed">34683148</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, Lindborg SR, Goyal NA, et al. (2022) A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis. Muscle Nerve. 65(3):291&#x2013;302. doi: 10.1002/mus.27472. Epub 2022 Jan 5. Erratum in: Muscle Nerve. 2022 Oct;66(4):E26-E27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9305113</ArticleId><ArticleId IdType="pubmed">34890069</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Tong G, Ballard C. Treatment combinations for alzheimer's disease: current and future pharmacotherapy options. J Alzheimers Dis. 2019;67(3):779&#x2013;794. doi: 10.3233/JAD-180766.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180766</ArticleId><ArticleId IdType="pmc">PMC6398562</ArticleId><ArticleId IdType="pubmed">30689575</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielyan L, Beer-Hammer S, Stolzing A, et al. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of alzheimer&#x2019;s and parkinson&#x2019;s disease. Cell Transplant. 2014;23(Suppl 1):S123&#x2013;139. doi: 10.3727/096368914X684970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368914X684970</ArticleId><ArticleId IdType="pubmed">25302802</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantuma E, Merchant S, Sugaya K. Stem cells for the treatment of neurodegenerative diseases. Stem Cell ResTher. 2010;1:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025439</ArticleId><ArticleId IdType="pubmed">21144012</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behav Brain Res 25;214(2):193&#x2013;200</Citation><ArticleIdList><ArticleId IdType="pubmed">20493905</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo M, Mancini A, Bellingacci L, Gaetani L, Mazzocchetti P, Zelante T, La Barbera L, De Luca A, Tantucci M, Tozzi A, et al. Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis. Cell Rep. 2021;37:110094. doi: 10.1016/j.celrep.2021.110094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110094</ArticleId><ArticleId IdType="pubmed">34879272</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315&#x2013;317</Citation><ArticleIdList><ArticleId IdType="pubmed">16923606</ArticleId></ArticleIdList></Reference><Reference><Citation>Doshmanziari M, Shirian S, Kouchakian MR, Moniri SF, Jangnoo S, Mohammadi N, Zafari F. Mesenchymal stem cells act as stimulators of neurogenesis and synaptic function in a rat model of alzheimer's disease. Heliyon. 2021;7(9):e07996. doi: 10.1016/j.heliyon.2021.e07996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2021.e07996</ArticleId><ArticleId IdType="pmc">PMC8461353</ArticleId><ArticleId IdType="pubmed">34589625</ArticleId></ArticleIdList></Reference><Reference><Citation>Drews K, Jozefczuk J, Prigione A, Adjaye J. Human induced pluripotent stem cells&#x2013;from mechanisms to clinical applications. J Mol Med (berl) 2012;90(7):735&#x2013;745. doi: 10.1007/s00109-012-0913-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-012-0913-0</ArticleId><ArticleId IdType="pubmed">22643868</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulak J. Kom&#xf3;rki macierzyste: zastosowania, perspektywy, nieporozumienia. Nauka. 2020;1:99&#x2013;123.</Citation></Reference><Reference><Citation>Elia CA, Tamborini M, Rasile M, Desiato G, Marchetti S, Swuec P, Mazzitelli S, Clemente F, Anselmo A, Matteoli M, et al. Intracerebral injection of extracellular vesicles from mesenchymal stem cells exerts reduced A&#x3b2; plaque burden in early stages of a preclinical model of alzheimer&#x2019;s disease. Cells. 2019;8:1059. doi: 10.3390/cells8091059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8091059</ArticleId><ArticleId IdType="pmc">PMC6770482</ArticleId><ArticleId IdType="pubmed">31510042</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskandari N, Boroujeni ME, Abdollahifar MA, Piryaei A, Khodagholi F, Mirbehbahani SH, Siroosi S, Moghaddam MH, Aliaghaei A, Sadeghi Y. Transplantation of human dental pulp stem cells compensates for striatal atrophy and modulates neuro-inflammation in 3-nitropropionic acid rat model of Huntington's disease. Neurosci Res. 2021;170:133&#x2013;144. doi: 10.1016/j.neures.2020.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2020.12.002</ArticleId><ArticleId IdType="pubmed">33359180</ArticleId></ArticleIdList></Reference><Reference><Citation>Farinazzo A, Angiari S, Turano, et al. Nanovesicles from adipose-derived mesenchymal stem cells inhibit T lymphocyte trafficking and ameliorate chronic experimental autoimmune encephalomyelitis. Sci Rep. 2018;8:7473. doi: 10.1038/s41598-018-25676-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25676-2</ArticleId><ArticleId IdType="pmc">PMC5945853</ArticleId><ArticleId IdType="pubmed">29748664</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassas A, Kimiskidis VK, Sakellari I, et al. Long-term results of stem cell transplantation for MS: a single-center experience. Neurology. 2011;76(12):1066&#x2013;1070. doi: 10.1212/WNL.0b013e318211c537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318211c537</ArticleId><ArticleId IdType="pubmed">21422458</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman EL, Boulis NM, Hur J, et al. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. Ann Neurol. 2014;75(3):363&#x2013;373. doi: 10.1002/ana.24113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24113</ArticleId><ArticleId IdType="pmc">PMC4005820</ArticleId><ArticleId IdType="pubmed">24510776</ArticleId></ArticleIdList></Reference><Reference><Citation>Filadi R, Pizzo P. Defective autophagy and Alzheimer&#x2019;s disease: is calcium the key? Neural RegenRes. 2019;14:2081&#x2013;2082. doi: 10.4103/1673-5374.262584.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.262584</ArticleId><ArticleId IdType="pmc">PMC6788238</ArticleId><ArticleId IdType="pubmed">31397341</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipi T, Hermanova Z, Tureckova J, Vanatko O, Anderova AM. Glial cells-the strategic targets in amyotrophic lateral sclerosis treatment. J Clin Med. 2020;9:261. doi: 10.3390/jcm9010261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9010261</ArticleId><ArticleId IdType="pmc">PMC7020059</ArticleId><ArticleId IdType="pubmed">31963681</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink KD, Rossignol J, Crane AT, et al. Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: Behavioral and neuropathological analysis. Stem Cell Res Ther. 2013;4:130. doi: 10.1186/scrt341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/scrt341</ArticleId><ArticleId IdType="pmc">PMC3854759</ArticleId><ArticleId IdType="pubmed">24456799</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, et al. Developing stem cell therapies for juvenile and adult &#x2013;onset Huntington&#x2019;s disease. Regen Med. 2015;10:623&#x2013;646. doi: 10.2217/rme.15.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/rme.15.25</ArticleId><ArticleId IdType="pmc">PMC6785015</ArticleId><ArticleId IdType="pubmed">26237705</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel Z, Esteban F, Rodriguez B, Fu T, Ai X, Cai L. Diversity of adult neural stem and progenitor cells in physiology and disease. Cells. 2021;10(8):2045. doi: 10.3390/cells10082045.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082045</ArticleId><ArticleId IdType="pmc">PMC8392301</ArticleId><ArticleId IdType="pubmed">34440814</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong CY, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: a clinical hurdle. J Cell Biochem. 2010;111(4):769&#x2013;781. doi: 10.1002/jcb.22775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.22775</ArticleId><ArticleId IdType="pubmed">20665544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford H. Clinical presentation and diagnosis of multiple sclerosis. Clin Med. 2020;20:380&#x2013;383. doi: 10.7861/clinmed.2020-0292.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0292</ArticleId><ArticleId IdType="pmc">PMC7385797</ArticleId><ArticleId IdType="pubmed">32675142</ArticleId></ArticleIdList></Reference><Reference><Citation>Frausin S, Viventi S, VergaFalzacappa L, Quattromani MJ, Leanza G, Tommasini A, et al. Wharton&#x2019;s jelly derived mesenchymal stromal cells: biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. Acta Histochem. 2015;117:329&#x2013;338. doi: 10.1016/j.acthis.2015.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acthis.2015.02.005</ArticleId><ArticleId IdType="pubmed">25747736</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guineapig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">5523063</ArticleId></ArticleIdList></Reference><Reference><Citation>Gbaguidi B, Guillemin F, Soudant M, Debouverie M, Mathey G, Epstein J. Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine France. Sci Rep. 2022;12:1001. doi: 10.1038/s41598-022-04836-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-04836-5</ArticleId><ArticleId IdType="pmc">PMC8770673</ArticleId><ArticleId IdType="pubmed">35046460</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli E, Vahsen BF, Calder EL, Xu Y, Scaber J, Gray E, Dafinca R, Talbot K, Studer L. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation. Cell Stem Cell. 2022;29(1):11&#x2013;35. doi: 10.1016/j.stem.2021.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.12.008</ArticleId><ArticleId IdType="pmc">PMC8785905</ArticleId><ArticleId IdType="pubmed">34995492</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass JD, Boulis NM, Johe K, et al. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells. 2012;30(6):1144&#x2013;1151. doi: 10.1002/stem.1079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1079</ArticleId><ArticleId IdType="pubmed">22415942</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;jska A, Michal Nyka AW. Stemcells in neurology. AktualnNeurol. 2008;8(1):39&#x2013;48.</Citation></Reference><Reference><Citation>Goldmann T, Wieghofer P, Muller PF, Wolf Y, Varol D, Yona S, Brendecke SM, Kierdorf K, Staszewski O, Datta M, et al. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat Neurosci. 2013;16:1618&#x2013;16264. doi: 10.1038/nn.3531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3531</ArticleId><ArticleId IdType="pubmed">24077561</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, et al. Isolation of multipotent neural stem or progenitor cells from both the dentate gyrus and subventricular zone of a single adult mouse. Nat Protoc. 2012;7(11):2005&#x2013;2012. doi: 10.1038/nprot.2012.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2012.123</ArticleId><ArticleId IdType="pmc">PMC3652802</ArticleId><ArticleId IdType="pubmed">23080272</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Disatnik M-H, Monbureau M, Shamloo M, Mochly-Rosen D, Qi X. Inhibition of mitochondrial fragmentation diminishes Huntington&#x2019;s disease-associated neurodegeneration. J Clin Invest. 2013;123:5371&#x2013;88. doi: 10.1172/JCI70911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI70911</ArticleId><ArticleId IdType="pmc">PMC3859413</ArticleId><ArticleId IdType="pubmed">24231356</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurusamy N, Alsayari A, Rajasingh S, Rajasingh J. Adult stem cells for regenerative therapy. Prog Mol Biol Transl Sci. 2018;160:1&#x2013;22. doi: 10.1016/bs.pmbts.2018.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2018.07.009</ArticleId><ArticleId IdType="pubmed">30470288</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha S, Ahn S, Kim S, et al. In vivo imaging of human adipose-derived stem cells in alzheimer&#x2019;s disease animal model. J Biomed Opt. 2014;19:051206. doi: 10.1117/1.JBO.19.5.051206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/1.JBO.19.5.051206</ArticleId><ArticleId IdType="pubmed">24297061</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song S, Likhite S, Murtha MJ, Foust KD, Rao M, Eagle A, Kammesheidt A, Christensen A, Mendell JR, Burghes AH, Kaspar BK. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29(9):824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S, Musella A, Sepman H, Motta C, Studer V, et al. TNF -&#x3b1;-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol. 2012;237:296&#x2013;303. doi: 10.1016/j.expneurol.2012.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.07.010</ArticleId><ArticleId IdType="pubmed">22836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallett PJ, Cooper O, Sadi D, Robertson H, Mendez I, Isacson O. Long-term health of dopaminergic neuron transplants in Parkinson's disease patients. Cell Rep. 2014;7(6):1755&#x2013;61. doi: 10.1016/j.celrep.2014.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.05.027</ArticleId><ArticleId IdType="pmc">PMC4105701</ArticleId><ArticleId IdType="pubmed">24910427</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris VK, Yan QJ, Vyshkina T, Sahabi S, Liu X, Sadiq SA. Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis. J Neurol Sci. 2012;313:167&#x2013;177. doi: 10.1016/j.jns.2011.08.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.08.036</ArticleId><ArticleId IdType="pubmed">21962795</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris VK, Stark JW, Yang S, et al. Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study. Neurol Neuroimmunol Neuroinflamm. 2020;8(1):e928. doi: 10.1212/NXI.0000000000000928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000928</ArticleId><ArticleId IdType="pmc">PMC7738177</ArticleId><ArticleId IdType="pubmed">33277427</ArticleId></ArticleIdList></Reference><Reference><Citation>Hass R, Kasper C, B&#xf6;hm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissuederived MSC. Cell Commun Signal. 2011;9:12. doi: 10.1186/1478-811X-9-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1478-811X-9-12</ArticleId><ArticleId IdType="pmc">PMC3117820</ArticleId><ArticleId IdType="pubmed">21569606</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser SL, Cree BAC. Treatment of multiple sclerosis: a review. Am J Med. 2020;133(12):1380&#x2013;1390.e2. doi: 10.1016/j.amjmed.2020.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2020.05.049</ArticleId><ArticleId IdType="pmc">PMC7704606</ArticleId><ArticleId IdType="pubmed">32682869</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, et al. Ocrelizumab versus Interferon Beta-1a in relapsing multiple sclerosis. N Engl J Med. 2017;376:221&#x2013;234. doi: 10.1056/NEJMoa1601277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1601277</ArticleId><ArticleId IdType="pubmed">28002679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrot J, Imhof S, Wainger BJ. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. Neurobiol Dis. 2020;134:104680. doi: 10.1016/j.nbd.2019.104680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104680</ArticleId><ArticleId IdType="pmc">PMC7002167</ArticleId><ArticleId IdType="pubmed">31759135</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y, Lin HT, Lee CC, Tsai KJ. Effects of neural stem cell transplantation in Alzheimer's disease models. J Biomed Sci. 2020;27(1):29. doi: 10.1186/s12929-020-0622-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0622-x</ArticleId><ArticleId IdType="pmc">PMC6986162</ArticleId><ArticleId IdType="pubmed">31987051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedayatpour A, Ragerdi I, Pasbakhsh P, Kafami L, Atlasi N, PirhajatiMahabadi V, et al. Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis. Cell J. 2013;15:142&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712775</ArticleId><ArticleId IdType="pubmed">23862116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermann A, Storch A. Induced neural stem cells (iNSCs) in neurodegenerative diseases. J Neural Transm (vienna) 2013;120(Suppl 1):S19&#x2013;S25. doi: 10.1007/s00702-013-1042-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-013-1042-9</ArticleId><ArticleId IdType="pubmed">23720190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulisz D. Amyotrophic lateral sclerosis: disease state overview. Am J Manag Care. 2018;24(15 Suppl):S320&#x2013;S326.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207670</ArticleId></ArticleIdList></Reference><Reference><Citation>International Multiple Sclerosis Genetics Consortium Genetics analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45:1353&#x2013;1360. doi: 10.1038/ng.2770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2770</ArticleId><ArticleId IdType="pmc">PMC3832895</ArticleId><ArticleId IdType="pubmed">24076602</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam J, So KH, Kc E, Moon HC, Kim A, Hyun SH, Kim S, Park YS. Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington's disease. Stem Cell Res Ther. 2021;12(1):585. doi: 10.1186/s13287-021-02653-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-021-02653-7</ArticleId><ArticleId IdType="pmc">PMC8607638</ArticleId><ArticleId IdType="pubmed">34809707</ArticleId></ArticleIdList></Reference><Reference><Citation>Je G, Keyhanian K, Ghasemi M. Overview of stem cells therapy in amyotrophic lateral sclerosis. Neurol Res. 2021;43(8):616&#x2013;632. doi: 10.1080/01616412.2021.1893564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2021.1893564</ArticleId><ArticleId IdType="pubmed">33632084</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Q, Huang K, Lu F, et al. Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation. Gen Thorac Cardiovasc Surg. 2022;70(1):1&#x2013;10. doi: 10.1007/s11748-021-01696-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11748-021-01696-0</ArticleId><ArticleId IdType="pmc">PMC8732940</ArticleId><ArticleId IdType="pubmed">34510332</ArticleId></ArticleIdList></Reference><Reference><Citation>Justyna Kacperska M, Dominika Ksi&#x105;&#x17c;ek-Winiarek, Karol Jastrz&#x119;bski, et al. (2013) The attempts to use stem cells in the therapy of selected disorders of the nervous system&#x201d;, Aktualn Neurol. 13(2): 145&#x2013;156</Citation></Reference><Reference><Citation>Karussis D, Karageorgiou C, Vaknin-Dembinsky A. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol. 2010;67(10):1187&#x2013;119. doi: 10.1001/archneurol.2010.248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.248</ArticleId><ArticleId IdType="pmc">PMC3036569</ArticleId><ArticleId IdType="pubmed">20937945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol. 2008;65:753&#x2013;761. doi: 10.1001/archneur.65.6.753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.6.753</ArticleId><ArticleId IdType="pubmed">18541795</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann M, Evans H, Schaupp AL, Engler JB, Kaur G, Willing A, Kursawe N, Schubert C, Attfield KE, Fugger L, et al. Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis. Med. 2021;2:296&#x2013;312.e8. doi: 10.1016/j.medj.2021.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.01.006</ArticleId><ArticleId IdType="pmc">PMC7966680</ArticleId><ArticleId IdType="pubmed">33748804</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaguchi A. Neuronal delamination and outer radial glia generation in neocortical development. Front Cell Dev Biol. 2020;8:623573. doi: 10.3389/fcell.2020.623573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.623573</ArticleId><ArticleId IdType="pmc">PMC7892903</ArticleId><ArticleId IdType="pubmed">33614631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi T, Morizane A, Doi D, et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson&#x2019;s disease model. Nature. 2017;548:592&#x2013;596. doi: 10.1038/nature23664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23664</ArticleId><ArticleId IdType="pubmed">28858313</ArticleId></ArticleIdList></Reference><Reference><Citation>Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, et al. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology. 2009;87(1):26&#x2013;33. doi: 10.1002/jnr.21817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21817</ArticleId><ArticleId IdType="pmc">PMC3716408</ArticleId><ArticleId IdType="pubmed">23624566</ArticleId></ArticleIdList></Reference><Reference><Citation>Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, et al. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology. 2013;80:2022. doi: 10.1212/WNL.0b013e318294b304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318294b304</ArticleId><ArticleId IdType="pmc">PMC3716408</ArticleId><ArticleId IdType="pubmed">23624566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, Lee JI, Chang JW, Park S, Kim ST, Moon SW, Seo SW, Choi SJ, Na DL. Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial. Alzheimers Res Ther. 2021;13(1):154. doi: 10.1186/s13195-021-00897-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00897-2</ArticleId><ArticleId IdType="pmc">PMC8439008</ArticleId><ArticleId IdType="pubmed">34521461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim A, Lalonde K, Truesdell A, Gomes Welter P, Brocardo PS, Rosenstock TR, Gil-Mohapel J. New Avenues for the treatment of Huntington's disease. Int J Mol Sci. 2021;22(16):8363. doi: 10.3390/ijms22168363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168363</ArticleId><ArticleId IdType="pmc">PMC8394361</ArticleId><ArticleId IdType="pubmed">34445070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim A, Lalonde K, Truesdell A, et al. New avenues for the treatment of Huntington's disease. Int J Mol Sci. 2021;22(16):8363. doi: 10.3390/ijms22168363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168363</ArticleId><ArticleId IdType="pmc">PMC8394361</ArticleId><ArticleId IdType="pubmed">34445070</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippenberg S, Rath KJ, Boselt S, et al. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors. J Tissue Eng Regen Med. 2017;11(3):751&#x2013;764. doi: 10.1002/term.1972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/term.1972</ArticleId><ArticleId IdType="pubmed">25641599</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolagar TA, Farzaneh M, Nikkar N, Khoshnam SE. Human pluripotent stem cells in neurodegenerative diseases: potentials, advances and limitations. Curr Stem Cell Res Ther. 2020;15(2):102&#x2013;110. doi: 10.2174/1574888X14666190823142911.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574888X14666190823142911</ArticleId><ArticleId IdType="pubmed">31441732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo T, Funayama M, Tsukita K, et al. Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Rep. 2014;3(2):242&#x2013;249. doi: 10.1016/j.stemcr.2014.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2014.05.017</ArticleId><ArticleId IdType="pmc">PMC4175543</ArticleId><ArticleId IdType="pubmed">25254338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo T, et al. iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid beta combination for alzheimer's disease. Cell Rep. 2017;21(8):2304&#x2013;2312. doi: 10.1016/j.celrep.2017.10.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.10.109</ArticleId><ArticleId IdType="pubmed">29166618</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA. 1999;96:10711&#x2013;10716. doi: 10.1073/pnas.96.19.10711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.19.10711</ArticleId><ArticleId IdType="pmc">PMC17948</ArticleId><ArticleId IdType="pubmed">10485891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassmann H, Bradl M. Multiple sclerosis: experimental models and reality. Acta Neuropathol. 2017;133:223&#x2013;244. doi: 10.1007/s00401-016-1631-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1631-4</ArticleId><ArticleId IdType="pmc">PMC5250666</ArticleId><ArticleId IdType="pubmed">27766432</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassmann H, van Horssen J, Mahad D. Progressive multiple sclerosis: pathologyand pathogenesis. Nat Rev Neurol. 2012;8:647&#x2013;656. doi: 10.1038/nrneurol.2012.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.168</ArticleId><ArticleId IdType="pubmed">23007702</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JP, et al. Neural stem cell transplantation in mouse brain. Curr Protoc Neurosci. 2008 doi: 10.1002/0471142301.ns0310s42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142301.ns0310s42</ArticleId><ArticleId IdType="pubmed">18428671</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee ST, Im W, Ban JJ, et al. Exosome-based delivery of miR-124 in a Huntington&#x2019;s disease model. J MovDisord. 2017;10(1):45&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5288667</ArticleId><ArticleId IdType="pubmed">28122430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Liu JW, Lin SZ, et al. Advances in patient-specific induced pluripotent stem cells shed light on drug discovery for amyotrophic lateral sclerosis. Cell Transplant. 2018;27(9):1301&#x2013;1312. doi: 10.1177/0963689718785154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689718785154</ArticleId><ArticleId IdType="pmc">PMC6168987</ArticleId><ArticleId IdType="pubmed">30033758</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Liu J, Gu G, et al. Impact of neural stem cell-derived extracellular vesicles on mitochondrial dysfunction, sirtuin 1 level, and synaptic deficits in alzheimer&#x2019;s disease. J Neurochem. 2020;154:e15001. doi: 10.1111/jnc.15001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15001</ArticleId><ArticleId IdType="pubmed">32145065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lulu S, Graves J, Waubant E. Menarche increases relapse risk in pediatric multiple sclerosis. Mult Scler J. 2016;22:193&#x2013;200. doi: 10.1177/1352458515581873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458515581873</ArticleId><ArticleId IdType="pmc">PMC4636485</ArticleId><ArticleId IdType="pubmed">25948626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma DK, Bonaguidi MA, Ming GL, Song H. Adult neural stem cells in the mammalian central nervous system. Cell Res. 2009;19:672&#x2013;82. doi: 10.1038/cr.2009.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2009.56</ArticleId><ArticleId IdType="pmc">PMC2738865</ArticleId><ArticleId IdType="pubmed">19436263</ArticleId></ArticleIdList></Reference><Reference><Citation>Machali&#x144;ski B. Non-embryonic stem cells and regeneration of the nervous system. Pol Przegl Neurol. 2008;4(1):15&#x2013;19.</Citation></Reference><Reference><Citation>Madrazo I, Kopyov O, &#xc1;vila-Rodr&#xed;guez MA, et al. Transplantation of human neural progenitor cells (NPC) into putamina of parkinsonian patients: a case series study, safety and efficacy four years after surgery. Cell Transplant. 2019;28(3):269&#x2013;285. doi: 10.1177/0963689718820271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689718820271</ArticleId><ArticleId IdType="pmc">PMC6425108</ArticleId><ArticleId IdType="pubmed">30574805</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Morales PL, et al. Progress in stem cell therapy for major human neurological disorders. Stem Cell Rev. 2013;9(5):685&#x2013;699. doi: 10.1007/s12015-013-9443-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-013-9443-6</ArticleId><ArticleId IdType="pubmed">23681704</ArticleId></ArticleIdList></Reference><Reference><Citation>Mass E, Jacome-Galarza CE, Blank T, Lazarov T, Durham BH, Ozkaya N, Pastore A, Schwabenland M, Chung YR, Rosenblum MK, et al. A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease. Nature. 2017;549:389&#x2013;393. doi: 10.1038/nature23672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23672</ArticleId><ArticleId IdType="pmc">PMC6047345</ArticleId><ArticleId IdType="pubmed">28854169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mass RF, Vigne S, Pot C. Resolution of inflammation during multiple sclerosis. Semin Immunopathol. 2019;41:711&#x2013;726. doi: 10.1007/s00281-019-00765-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-019-00765-0</ArticleId><ArticleId IdType="pmc">PMC6881249</ArticleId><ArticleId IdType="pubmed">31732775</ArticleId></ArticleIdList></Reference><Reference><Citation>Massirer KB, et al. Maintenance and differentiation of neural stem cells. Wiley Interdiscip Rev Syst Biol Med. 2011;3(1):107&#x2013;114. doi: 10.1002/wsbm.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wsbm.100</ArticleId><ArticleId IdType="pubmed">21061307</ArticleId></ArticleIdList></Reference><Reference><Citation>Matejuk A, Ransohoff RM. Crosstalk between astrocytes and microglia: an overview. Front Immunol. 2020;11:1416. doi: 10.3389/fimmu.2020.01416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01416</ArticleId><ArticleId IdType="pmc">PMC7378357</ArticleId><ArticleId IdType="pubmed">32765501</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattis VB, Tom C, Akimov S, Saeedian J, &#xd8;stergaard ME, Southwell AL, et al. HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity. Hum Mol Genet. 2015;24:3257&#x2013;71. doi: 10.1093/hmg/ddv080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv080</ArticleId><ArticleId IdType="pmc">PMC4424959</ArticleId><ArticleId IdType="pubmed">25740845</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazini L, Rochette L, Amine M, Malka G. Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs) Int J Mol Sci. 2019;20(10):2523. doi: 10.3390/ijms20102523.PMID:31121953;PMCID:PMC6566837.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20102523.PMID:31121953;PMCID:PMC6566837</ArticleId><ArticleId IdType="pmc">PMC6566837</ArticleId><ArticleId IdType="pubmed">31121953</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, Gelati M, Profico DC, et al. Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med. 2015;27(13):17. doi: 10.1186/s12967-014-0371-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-014-0371-2</ArticleId><ArticleId IdType="pmc">PMC4359401</ArticleId><ArticleId IdType="pubmed">25889343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, Gelati M, Profico DC, et al. Results from phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: a long-term outcome. Stem Cells Transl Med. 2019;8(9):887&#x2013;897. doi: 10.1002/sctm.18-0154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.18-0154</ArticleId><ArticleId IdType="pmc">PMC6708070</ArticleId><ArticleId IdType="pubmed">31104357</ArticleId></ArticleIdList></Reference><Reference><Citation>McColgan P, Tabrizi SJ. Huntington's disease: a clinical review. Eur J Neurol. 2018;25(1):24&#x2013;34. doi: 10.1111/ene.13413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13413</ArticleId><ArticleId IdType="pubmed">28817209</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy MK, Martinez TN, Ruhn KA, et al. Autologous transplants of adipose-derived adult stromal (ADAS) cells afford dopaminergic neuroprotection in a model of parkinson&#x2019;s disease. Exp Neurol. 2008;210:14&#x2013;29. doi: 10.1016/j.expneurol.2007.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2007.10.011</ArticleId><ArticleId IdType="pmc">PMC2394500</ArticleId><ArticleId IdType="pubmed">18061169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Kaye W, Raymond J, et al. Prevalence of amyotrophic lateral sclerosis &#x2014;United States, 2014. MMWR Morb Mortal Wkly Rep. 2018;67(7):216&#x2013;218. doi: 10.15585/mmwr.mm6707a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6707a3</ArticleId><ArticleId IdType="pmc">PMC5858037</ArticleId><ArticleId IdType="pubmed">29470458</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura K, Okada Y, Aoi T, et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 2009;27(8):743&#x2013;745. doi: 10.1038/nbt.1554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1554</ArticleId><ArticleId IdType="pubmed">19590502</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med. 2017;376:209&#x2013;220. doi: 10.1056/NEJMoa1606468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1606468</ArticleId><ArticleId IdType="pubmed">28002688</ArticleId></ArticleIdList></Reference><Reference><Citation>Morizane A, Kikuchi T, Hayashi T, et al. MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nat Commun. 2017;8:385. doi: 10.1038/s41467-017-00926-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00926-5</ArticleId><ArticleId IdType="pmc">PMC5577234</ArticleId><ArticleId IdType="pubmed">28855509</ArticleId></ArticleIdList></Reference><Reference><Citation>Mross K, Jankowska M, Meller A, Machowska-Sempruch K, Nowacki P, Masztalewicz M, Pawlukowska W. Sensory integration disorders in patients with multiple sclerosis. J Clin Med. 2022;11:5183. doi: 10.3390/jcm11175183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11175183</ArticleId><ArticleId IdType="pmc">PMC9457514</ArticleId><ArticleId IdType="pubmed">36079113</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu S, Wang J, Zhou G, Peng W, He Z, Zhao Z, Mo CP, Qu J, Zhang J. Transplantation of induced pluripotent stem cells improves functional recovery in Huntington&#x2019;s disease rat model. PLoS ONE. 2014;9:101185. doi: 10.1371/journal.pone.0101185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0101185</ArticleId><ArticleId IdType="pmc">PMC4108311</ArticleId><ArticleId IdType="pubmed">25054283</ArticleId></ArticleIdList></Reference><Reference><Citation>Munter J, Shafarevich I, Liundup A, et al. Neuro-Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice. CNS Neurosci Ther. 2020;26(5):504&#x2013;517. doi: 10.1111/cns.13280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13280</ArticleId><ArticleId IdType="pmc">PMC7163689</ArticleId><ArticleId IdType="pubmed">31867846</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraro PA, Pasquini M, Atkins HL, et al. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurol. 2017;74:459&#x2013;469. doi: 10.1001/jamaneurol.2016.5867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.5867</ArticleId><ArticleId IdType="pmc">PMC5744858</ArticleId><ArticleId IdType="pubmed">28241268</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraro PA, Martin R, Mancardi GL, et al. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis. Nat Rev Neurol. 2017;13:391&#x2013;405. doi: 10.1038/nrneurol.2017.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.81</ArticleId><ArticleId IdType="pubmed">28621766</ArticleId></ArticleIdList></Reference><Reference><Citation>Muratore CR, et al. The familial Alzheimer's disease APPV717I mutation alters APP processing and tau expression in iPSC-derived neurons. Hum Mol Genet. 2014;23(13):3523&#x2013;3536. doi: 10.1093/hmg/ddu064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu064</ArticleId><ArticleId IdType="pmc">PMC4049307</ArticleId><ArticleId IdType="pubmed">24524897</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhr KM, Torkildsen O, Lossius A, Bo L, Holmoy T. B cell depletion in the treatment of multiple sclerosis. Expert Opin Biol Ther. 2019;19:261&#x2013;271. doi: 10.1080/14712598.2019.1568407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2019.1568407</ArticleId><ArticleId IdType="pubmed">30632834</ArticleId></ArticleIdList></Reference><Reference><Citation>Namzaric . (memantine and donepezil hydrochlorides). Full Prescribing Information. Irvine: Allergan USA Inc; 2016.</Citation></Reference><Reference><Citation>Nizzardo M, Simone C, Rizzo F, et al. Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model. Hum Mol Genet. 2014;23(2):342&#x2013;354. doi: 10.1093/hmg/ddt425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt425</ArticleId><ArticleId IdType="pmc">PMC3869354</ArticleId><ArticleId IdType="pubmed">24006477</ArticleId></ArticleIdList></Reference><Reference><Citation>Papoutsi M, Labuschagne I, Tabrizi SJ, Stout JC. The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation. MovDisord. 2014;29:673&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">24757115</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HJ, Lee PH, Bang OY, et al. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson&#x2019;s disease. J Neurochem. 2008;107:141&#x2013;151. doi: 10.1111/j.1471-4159.2008.05589.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05589.x</ArticleId><ArticleId IdType="pubmed">18665911</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J, Zeng X. The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases. Stem Cell ResTher. 2011;2:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3219063</ArticleId><ArticleId IdType="pubmed">21861938</ArticleId></ArticleIdList></Reference><Reference><Citation>Penney J, Ralvenius WT, Tsai LH. Modeling alzheimer's disease with iPSC-derived brain cells. Mol Psychiatr. 2020;25(1):148&#x2013;167. doi: 10.1038/s41380-019-0468-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0468-3</ArticleId><ArticleId IdType="pmc">PMC6906186</ArticleId><ArticleId IdType="pubmed">31391546</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrou P, Kassis I, Levin N, Paul F, Backner Y, Benoliel T, Oertel FC, Scheel M, Hallimi M, Yaghmour N, Hur TB, Ginzberg A, Levy Y, Abramsky O, Karussis D. Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain. 2020;143(12):3574&#x2013;3588. doi: 10.1093/brain/awaa333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa333</ArticleId><ArticleId IdType="pubmed">33253391</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrou P, Kassis I, Yaghmour NE, Ginzberg A, Karussis D. A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis. Front Biosci (landmark Ed) 2021;26(10):693&#x2013;706. doi: 10.52586/4980.</Citation><ArticleIdList><ArticleId IdType="doi">10.52586/4980</ArticleId><ArticleId IdType="pubmed">34719198</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrou P, Kassis I, Ginzberg A, et al. Effects of mesenchymal stem cell transplantation on cerebrospinal fluid biomarkers in progressive multiple sclerosis. Stem Cells Transl Med. 2022;11(1):55&#x2013;58. doi: 10.1093/stcltm/szab017.PMID:35641166;PMCID:PMC8895488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/stcltm/szab017.PMID:35641166;PMCID:PMC8895488</ArticleId><ArticleId IdType="pmc">PMC8895488</ArticleId><ArticleId IdType="pubmed">35641166</ArticleId></ArticleIdList></Reference><Reference><Citation>Phinney DG, Prockop DJ (2007) Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells 25(11):2896-902.</Citation><ArticleIdList><ArticleId IdType="pubmed">17901396</ArticleId></ArticleIdList></Reference><Reference><Citation>Popescu IR, Nicaise C, Liu S, et al. Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis. Stem Cells Transl Med. 2013;2(3):167&#x2013;174. doi: 10.5966/sctm.2012-0042.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2012-0042</ArticleId><ArticleId IdType="pmc">PMC3659761</ArticleId><ArticleId IdType="pubmed">23413376</ArticleId></ArticleIdList></Reference><Reference><Citation>Prince M, Ali GC, Guerchet M, Prina AM, Albanese E, Wu YT. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther. 2016;8(1):23. doi: 10.1186/s13195-016-0188-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-016-0188-8</ArticleId><ArticleId IdType="pmc">PMC4967299</ArticleId><ArticleId IdType="pubmed">27473681</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarrell O, O&#x2019;Donovan KL, Bandmann O, Strong M. The prevalence of juvenile Huntington&#x2019;s disease: A review of the literature and meta-analysis. PLoSCurr. 2012 doi: 10.1371/4f8606b742ef3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/4f8606b742ef3</ArticleId><ArticleId IdType="pmc">PMC3426104</ArticleId><ArticleId IdType="pubmed">22953238</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond J, et al. Prevalence of amyotrophic lateral sclerosis&#x2014;United States, 2014. MMWR Morb Mortal Wkly Rep. 2018;67(7):216&#x2013;218. doi: 10.15585/mmwr.mm6707a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6707a3</ArticleId><ArticleId IdType="pmc">PMC5858037</ArticleId><ArticleId IdType="pubmed">29470458</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med. 2018;378:169&#x2013;180. doi: 10.1056/NEJMra1401483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1401483</ArticleId><ArticleId IdType="pmc">PMC6942519</ArticleId><ArticleId IdType="pubmed">29320652</ArticleId></ArticleIdList></Reference><Reference><Citation>Reidling JC, Rela&#xf1;o-Gin&#xe9;s A, Holley SM, et al. Human neural stem cell transplantation rescues functional deficits in R6/2 and Q140 Huntington&#x2019;s disease mice. Stem Cell Rep. 2018;10:58&#x2013;72. doi: 10.1016/j.stemcr.2017.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.11.005</ArticleId><ArticleId IdType="pmc">PMC5768890</ArticleId><ArticleId IdType="pubmed">29233555</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice CM, Halfpenny CA, Scolding NJ. Stem cells for the treatment of neurological disease. Transfus Med. 2003;13:351&#x2013;361. doi: 10.1111/j.1365-3148.2003.00463.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3148.2003.00463.x</ArticleId><ArticleId IdType="pubmed">14651741</ArticleId></ArticleIdList></Reference><Reference><Citation>Ring KL, An MC, Zhang N, O&#x2019;Brien RN, Ramos EM, Gao F, et al. Genomic analysis reveals disruption of striatal neuronal development and therapeutic targets in human Huntington&#x2019;s disease neural ste m cells. Stem Cell Rep. 2015;5:1023&#x2013;1038. doi: 10.1016/j.stemcr.2015.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2015.11.005</ArticleId><ArticleId IdType="pmc">PMC4682390</ArticleId><ArticleId IdType="pubmed">26651603</ArticleId></ArticleIdList></Reference><Reference><Citation>Riordan NH, Morales I, Fern&#xe1;ndez G, Allen N, Fearnot NE, Leckrone ME, Markovich DJ, Mansfield D, Avila D, Patel AN, Kesari S, Paz RJ. Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis. J Transl Med. 2018;16(1):57. doi: 10.1186/s12967-018-1433-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1433-7</ArticleId><ArticleId IdType="pmc">PMC5845260</ArticleId><ArticleId IdType="pubmed">29523171</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz K, Schmitz F. Synapse dysfunctions in multiple sclerosis. Int J Mol Sci. 2023;24(2):1639. doi: 10.3390/ijms24021639.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021639</ArticleId><ArticleId IdType="pmc">PMC9862173</ArticleId><ArticleId IdType="pubmed">36675155</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer JS, Song B, Herrington TM, et al. Personalized iPSC-derived dopamine progenitor cells for Parkinson&#x2019;s disease. N Engl J Med. 2020;382(20):1926&#x2013;1932. doi: 10.1056/NEJMoa1915872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1915872</ArticleId><ArticleId IdType="pmc">PMC7288982</ArticleId><ArticleId IdType="pubmed">32402162</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbazi E, et al. Reprogramming of somatic cells to induced neural stem cells. Methods. 2018;133:21&#x2013;28. doi: 10.1016/j.ymeth.2017.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2017.09.007</ArticleId><ArticleId IdType="pubmed">28939501</ArticleId></ArticleIdList></Reference><Reference><Citation>Shevchenko JL, Kuznetsov AN, Ionova TI, et al. Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis. Exp Hematol. 2012;40(11):892&#x2013;898. doi: 10.1016/j.exphem.2012.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exphem.2012.07.003</ArticleId><ArticleId IdType="pubmed">22771495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinenko SA, Ponomartsev SV, Tomilin AN. Human artificial chromosomes for pluripotent stem cell - based tissue replacement therapy. Exp Cell Res. 2020;389(1):111882. doi: 10.1016/j.yexcr.2020.111882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2020.111882</ArticleId><ArticleId IdType="pubmed">32017931</ArticleId></ArticleIdList></Reference><Reference><Citation>Siwek T, Jezierska-Wo&#x17a;niak K, Maksymowicz S, et al. Repeat administration of bone marrow-derived mesenchymal stem cells for treatment of amyotrophic lateral sclerosis. Med Sci Monit. 2020;26:e927484. doi: 10.12659/MSM.927484.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.927484</ArticleId><ArticleId IdType="pmc">PMC7737405</ArticleId><ArticleId IdType="pubmed">33301428</ArticleId></ArticleIdList></Reference><Reference><Citation>Soler R, Fullhase C, et al. Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease. J Urol. 2012;187:1491&#x2013;1497. doi: 10.1016/j.juro.2011.11.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2011.11.079</ArticleId><ArticleId IdType="pubmed">22341818</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoddard-Bennett T, Reijo Pera R. Treatment of parkinson&#x2019;s disease through, personalized medicine and induced pluripotent stem cells. Cells. 2019;8(1):26. doi: 10.3390/cells8010026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8010026</ArticleId><ArticleId IdType="pmc">PMC6357081</ArticleId><ArticleId IdType="pubmed">30621042</ArticleId></ArticleIdList></Reference><Reference><Citation>Surma A, KamilMaci&#x105;g, (2020) Neurodegenerative diseases - symptoms, diagnosis, treatment, Copyright by the Foundation for the Promotion of Science and Development TYGIEL, Lublin</Citation></Reference><Reference><Citation>Teng YD, Benn SC, Kalkanis SN, et al. Multimodal actions of neural stem cells in a mouse model of ALS: a meta -analysis. Sci Transl Med. 2012;4(165):161ral164. doi: 10.1126/scitranslmed.3004579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004579</ArticleId><ArticleId IdType="pubmed">23253611</ArticleId></ArticleIdList></Reference><Reference><Citation>Terashima T, Kojima H, Urabe H, et al. Stem cell factor-activated bone marrow ameliorates amyotrophic lateral sclerosis by promoting protective microglial migration. J Neurosci Res. 2014;92(7):856&#x2013;869. doi: 10.1002/jnr.23368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23368</ArticleId><ArticleId IdType="pmc">PMC4061499</ArticleId><ArticleId IdType="pubmed">24936617</ArticleId></ArticleIdList></Reference><Reference><Citation>Terashima T, Kobashi S, Watanabe Y, et al. Enhancing the therapeutic efficacy of bone marrow-derived mononuclear cells with growth factor-expressing mesenchymal stem cells for ALS in mice. iScience. 2020;23(11):101764. doi: 10.1016/j.isci.2020.101764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101764</ArticleId><ArticleId IdType="pmc">PMC7677706</ArticleId><ArticleId IdType="pubmed">33251493</ArticleId></ArticleIdList></Reference><Reference><Citation>Tousley A, Kegel-Gleason KB. Induced pluripotent stem cells in huntington's disease research: progress and opportunity. J Huntingtons Dis. 2016;5(2):99&#x2013;131. doi: 10.3233/JHD-160199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JHD-160199</ArticleId><ArticleId IdType="pmc">PMC4942721</ArticleId><ArticleId IdType="pubmed">27372054</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsiftsoglou AS. Erythropoietin (EPO) as a key regulator of erythropoiesis, bone remodeling and endothelial transdifferentiation of multipotent mesenchymal stem cells (MSCs): implications in regenerative medicine. Cells. 2021;10(8):2140. doi: 10.3390/cells10082140.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082140</ArticleId><ArticleId IdType="pmc">PMC8391952</ArticleId><ArticleId IdType="pubmed">34440909</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuazon JP, Castelli V, Lee JY, Desideri GB, Stuppia L, Cimini AM, Borlongan CV. Neural stem cells. AdvExp. Med Biol. 2019;1201:79&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">31898782</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G, Lakatos A, Patani R. Human stem cell-derived astrocytes: specification and relevance for neurological disorders. Curr Stem Cell Rep. 2016;2:236&#x2013;247. doi: 10.1007/s40778-016-0049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40778-016-0049-1</ArticleId><ArticleId IdType="pmc">PMC4972864</ArticleId><ArticleId IdType="pubmed">27547709</ArticleId></ArticleIdList></Reference><Reference><Citation>Uccelli A, Laroni A, Ali R, Battaglia MA, Blinkenberg M, Brundin L, Clanet M, Fernandez O, Marriot J, Muraro P, Nabavi SM, Oliveri RS, Radue E, RamoTello C, Schiavetti I, Sellner J, Sorensen PS, Sormani MP, Wuerfel JT, Freedman MS, MESEMS investigators Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. Lancet Neurol. 2021;20(11):917&#x2013;929. doi: 10.1016/S1474-4422(21)00301-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00301-X</ArticleId><ArticleId IdType="pubmed">34687636</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Meer LB, van Duijn E, Wolterbeek R, Tibben A. Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer. Clin Genet. 2012;81:18&#x2013;23. doi: 10.1111/j.1399-0004.2011.01778.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2011.01778.x</ArticleId><ArticleId IdType="pubmed">21895638</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan A, Johnson RT. Infections and multiple sclerosis. Handb Clin Neurol. 2014;122:151&#x2013;171. doi: 10.1016/B978-0-444-52001-2.00007-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-52001-2.00007-8</ArticleId><ArticleId IdType="pmc">PMC7152154</ArticleId><ArticleId IdType="pubmed">24507517</ArticleId></ArticleIdList></Reference><Reference><Citation>Visweswaran M, Hendrawan K, Massey JC, et al. (2022) Sustained immunotolerance in multiple sclerosis after stem cell transplant. Ann ClinTransl Neurol. 2022;9(2):206&#x2013;220. doi: 10.1002/acn3.51510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51510</ArticleId><ArticleId IdType="pmc">PMC8862434</ArticleId><ArticleId IdType="pubmed">35106961</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Mult Scler J. 2020;26:1816&#x2013;1821. doi: 10.1177/1352458520970841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458520970841</ArticleId><ArticleId IdType="pmc">PMC7720355</ArticleId><ArticleId IdType="pubmed">33174475</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, Kazuki Y, Kazuki K, et al. Use of a human artificial chromosome for delivering trophic factors in a rodent model of amyotrophic lateral sclerosis. Mol Ther Nucleic Acids. 2015;4(10):e253. doi: 10.1038/mtna.2015.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mtna.2015.28</ArticleId><ArticleId IdType="pmc">PMC4881756</ArticleId><ArticleId IdType="pubmed">26440597</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Y, Jin S. Production of neural stem cells from human pluripotent stem cells. J Biotechnol. 2014;188:122&#x2013;129. doi: 10.1016/j.jbiotec.2014.07.453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiotec.2014.07.453</ArticleId><ArticleId IdType="pubmed">25150215</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenceslau CV, de Souza DM, Mambelli-Lisboa NC, Ynoue LH, Araldi RP, da Silva JM, Pagani E, Haddad MS, Kerkis I. Restoration of BDNF, DARPP32, and D2R expression following intravenous infusion of human immature dental pulp stem cells in Huntington's disease 3-NP rat model. Cells. 2022;11(10):1664. doi: 10.3390/cells11101664.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11101664</ArticleId><ArticleId IdType="pmc">PMC9139280</ArticleId><ArticleId IdType="pubmed">35626701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenceslau CV, Kerkis I, Pompeia C, Haddad MS (2017) Pluripotent stem cells to model and treat huntington&#x2019;s disease. In: Nagehan Ersoy Tunali (Eds) Huntington&#x2019;s disease&#x2014;molecular pathogenesis and current models. InTech, Palm Beach</Citation></Reference><Reference><Citation>Wilkins A. Cerebellar dysfunction in multiple sclerosis. Front Neurol. 2017;8:312. doi: 10.3389/fneur.2017.00312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00312</ArticleId><ArticleId IdType="pmc">PMC5487391</ArticleId><ArticleId IdType="pubmed">28701995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y-Y, Chiu F-L, Yeh C-S, et al. Opportunities and challenges for the use of induced pluripotent stem cells in modeling neurodegenerative disease. OpenBiol. 2019;9:180177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6367134</ArticleId><ArticleId IdType="pubmed">30958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia M, Zhao T, Wang X, et al. Brain-derived neurotrophic factor and its applications through nanosystem delivery. Iran J Pharm Res. 2021;20(4):137&#x2013;151. doi: 10.22037/ijpr.2021.115705.15484.</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/ijpr.2021.115705.15484</ArticleId><ArticleId IdType="pmc">PMC8842625</ArticleId><ArticleId IdType="pubmed">35194435</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie C, Liu YQ, Guan YT, Zhang GX. Induced stem cells as a novel multiple sclerosis therapy. Curr Stem Cell Res Ther. 2016;11(4):313&#x2013;320. doi: 10.2174/1574888X10666150302110013.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574888X10666150302110013</ArticleId><ArticleId IdType="pmc">PMC4859307</ArticleId><ArticleId IdType="pubmed">25732737</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin H, Katakowski M, Wang M, et al. MicroRNA-17-92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats. Stroke. 2017;48:747&#x2013;753. doi: 10.1161/STROKEAHA.116.015204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.015204</ArticleId><ArticleId IdType="pmc">PMC5330787</ArticleId><ArticleId IdType="pubmed">28232590</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi T, et al. Modeling familial alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet. 2011;20(23):4530&#x2013;4539. doi: 10.1093/hmg/ddr394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr394</ArticleId><ArticleId IdType="pubmed">21900357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka S. Pluripotent stem cell-based cell therapypromise and challenges. Cell Stem Cell. 2020;27(4):523&#x2013;531. doi: 10.1016/j.stem.2020.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.09.014</ArticleId><ArticleId IdType="pubmed">33007237</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan M, Sun M, Zhou Y, et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton&#x2019;s jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson&#x2019;s disease in a rhesus monkey model. PLoS ONE. 2013;8:e64000. doi: 10.1371/journal.pone.0064000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064000</ArticleId><ArticleId IdType="pmc">PMC3665802</ArticleId><ArticleId IdType="pubmed">23724014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakrzewski W, Dobrzy&#x144;ski M, Szymonowicz M, et al. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10:68. doi: 10.1186/s13287-019-1165-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-019-1165-5</ArticleId><ArticleId IdType="pmc">PMC6390367</ArticleId><ArticleId IdType="pubmed">30808416</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, Zheng H, et al. A novel presenilin 1 mutation (F388L) identified in a Chinese family with early-onset Alzheimer&#x2019;s disease. Neurobiol Aging. 2017;50:168e1&#x2013;168e4. doi: 10.1016/j.neurobiolaging.2016.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.10.010</ArticleId><ArticleId IdType="pubmed">27836335</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Du F, Yang D, Yu C, Huang X, Liu W, et al. Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral stroke. BMC Neurosci. 2010;11:138. doi: 10.1186/1471-2202-11-138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-11-138</ArticleId><ArticleId IdType="pmc">PMC2974740</ArticleId><ArticleId IdType="pubmed">20973978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Liu GH, Yi F, et al. Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors. Protein Cell. 2014;5(1):48&#x2013;58. doi: 10.1007/s13238-013-0011-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-013-0011-2</ArticleId><ArticleId IdType="pmc">PMC3938849</ArticleId><ArticleId IdType="pubmed">24474194</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Gu GJ, Zhang Q, Liu JH, Zhang B, Guo Y, Wang MY, Gong QY, Xu JR. NSCs promote hippocampal neurogenesis, metabolic changes and synaptogenesis in APP/PS1 transgenic mice. Hippocampus. 2017;27(12):1250&#x2013;1263. doi: 10.1002/hipo.22794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.22794</ArticleId><ArticleId IdType="pubmed">28833933</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F-Q, Jiang J-L, Zhang J-T, et al. Current status and future prospects of stem cell therapy in alzheimer&#x2019;s disease&#x2019;. Neural Regen Res. 2020;15(2):242&#x2013;250. doi: 10.4103/1673-5374.265544.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.265544</ArticleId><ArticleId IdType="pmc">PMC6905342</ArticleId><ArticleId IdType="pubmed">31552889</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>